Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cutaneous vasculitis associated with propylthiouracil therapy.

M D Carrasco, C Riera, B Clotet

    Archives of Internal Medicine
    |September 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Multidisciplinary group intervention for the management of non-cancer chronic pain in adults].

    Semergen·2025
    Same author

    Cetylpyridinium Chloride Mouthwash to Reduce Shedding of Infectious SARS-CoV-2: A Double-Blind Randomized Clinical Trial.

    Journal of dental research·2022
    Same author

    Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro.

    Journal of dental research·2021
    Same author

    Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure Consortium.

    Journal of virus eradication·2021
    Same author

    First report on natural infection with Leishmania infantum in a domestic ferret (Mustela putorius furo) in Spain.

    Veterinary parasitology, regional studies and reports·2020
    Same author

    Clinical results of infrared coagulation as a treatment of high-grade anal dysplasia: a systematic review.

    Techniques in coloproctology·2019

    Propylthiouracil therapy can rarely cause cutaneous vasculitis, an immune complex-mediated condition. Stopping the drug typically resolves the vasculitic lesions, as seen in a patient with lower extremity and earlobe involvement.

    Area of Science:

    • Immunology
    • Dermatology
    • Pharmacology

    Background:

    • Propylthiouracil (PTU) is an antithyroid medication used to treat hyperthyroidism.
    • Cutaneous vasculitis is a rare but serious adverse effect associated with PTU treatment.
    • The pathogenesis is thought to involve circulating immune complexes.

    Observation:

    • A patient developed purpuric and hemorrhagic lesions on the lower extremities and earlobe after one year of PTU therapy.
    • The lesions exhibited characteristics of vasculitis, including potential evolution into necrotic ulcerations.
    • The clinical presentation was consistent with known, albeit uncommon, side effects of PTU.

    Findings:

    • Discontinuation of propylthiouracil therapy led to the complete resolution of the cutaneous vasculitic lesions.

    Related Experiment Videos

  • The duration of PTU treatment appeared correlated with the development of vasculitis.
  • The case highlights the direct relationship between PTU exposure and the onset/resolution of vasculitic manifestations.

    • Implications:

    • Withdrawal of propylthiouracil is the primary management strategy for PTU-induced cutaneous vasculitis.
    • While corticosteroids are often used, their efficacy in this specific context remains unproven.
    • This case underscores the importance of monitoring for dermatological adverse effects during long-term PTU treatment.